Tandem Diabetes Care, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Tandem Diabetes Care, Inc. (TNDM) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$226.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-19
- Tandem Diabetes Care, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$226.96M.
- Tandem Diabetes Care, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$78.16M.
- Tandem Diabetes Care, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$135.41M.
- Tandem Diabetes Care, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$94.03M, a 718.19% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$226.96M 10-K · filed 2026-02-19 | |
| 2024-12-31 | -$78.16M 10-K · filed 2026-02-19 | |
| 2023-12-31 | -$135.41M 10-K · filed 2026-02-19 | |
| 2022-12-31 | -$94.03M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $15.21M 10-K · filed 2024-02-21 | |
| 2020-12-31 | -$36.67M 10-K · filed 2023-02-22 | |
| 2019-12-31 | -$24.89M 10-K · filed 2022-02-22 | $24.90M 10-K · filed 2020-02-24 |
| 2018-12-31 | -$122.56M 10-K · filed 2021-02-24 | -$122.00M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |